NEW YORK, April 3 – Protein chip developer Zyomyx said Tuesday that Raju Kucherlapati has joined its board of directors.

Kucherlapati was a founder of Cell Genesys and Millennium Pharmaceuticals and currently serves as a director for Abgenix, Millennium, and Valentis.

Kucherlapati completed his postdoctoral work at Yale University and was awarded a PhD in genetics from the University of Illinois, Urbana.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.